Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
West China Hospital
West China Hospital
University of Erlangen-Nürnberg Medical School
Fudan University
M.D. Anderson Cancer Center
The Netherlands Cancer Institute
NRG Oncology
The Cleveland Clinic
M.D. Anderson Cancer Center
Sir Mortimer B. Davis - Jewish General Hospital
Thomas Jefferson University
University Hospital, Rouen
Assistance Publique - Hôpitaux de Paris
Institut du Cancer de Montpellier - Val d'Aurelle
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
UNICANCER
Second Affiliated Hospital of Nanchang University
Universitaire Ziekenhuizen KU Leuven
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
NRG Oncology
Beijing Friendship Hospital
Shanghai Jiao Tong University School of Medicine
Skane University Hospital
Rigshospitalet, Denmark
The Netherlands Cancer Institute
National Taiwan University Hospital
ARCAGY/ GINECO GROUP
University of Arizona
University Health Network, Toronto
Institut Curie
Boston University
Sun Yat-sen University
Cancer Research UK
Cancer Research UK
Zhongda Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Monash University
Monash University
Monash University
First Affiliated Hospital of Fujian Medical University
Inova Health Care Services
Zhujiang Hospital
University of British Columbia
Stanford University
Global Coalition for Adaptive Research
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Fudan University
Sixth Affiliated Hospital, Sun Yat-sen University